Vaxinano
Venture Round in 2024
Founded in 2016, Vaxinano is a biotechnology company dedicated to the preclinical and pharmaceutical development of human and veterinary vaccines. It specializes in creating vaccines and drug delivery systems that selectively target difficult pathogens like parasites, viruses, or bacteria.
Clouds of Care
Venture Round in 2024
Clouds of Care specializes in assisting HealthTech firms navigate algorithm validation to medical device software, with a focus on ensuring regulatory compliance.
Univercells
Series D in 2022
Univercells is a company specializing in high-density, low-cost biomanufacturing solutions aimed at enhancing the production of biologics, including antibodies, proteins, and vaccines. The company leverages innovative engineering and proprietary technologies, such as single-use systems and continuous process intensification, to significantly reduce capital investments by over 75% and the cost of goods by up to 90%. Univercells offers a range of services, including scale-X hydro, scale-X carbo, and NevoLine, which support both research and development and commercial-scale production of biologics. Additionally, the company provides integrated services like equipment confirmation, capacity and facility design, and bioprocess excellence, facilitating the scalability of cell and gene therapy manufacturers from clinical trials to commercial manufacturing. Through its commitment to making biologics more accessible and affordable, Univercells addresses critical global health challenges.
FLYX.cloud
Series A in 2022
FLYX.cloud empowers retail chains across various industries like Food, Grocery, and Fuel to maximize customer value in an omni-channel sales environment.
Smartflats
Series A in 2021
Smartflats is a company founded in 2012 by Tarik Hennen and Alexandre Szmaj, specializing in the construction and distribution of short-term rental apartments. It offers an online platform that allows clients to book stylish flats, providing the privacy and flexibility of a home combined with the comfort of hotel services. Guests benefit from amenities such as keyless check-in, full-time concierge service, and various in-apartment features including wireless internet, TVs, coffee makers, irons, and hairdryers. Smartflats aims to enhance the guest experience by ensuring a seamless and comfortable stay in prime urban locations.
Sortlist is a platform designed to simplify the process of finding suitable marketing and communication agencies for businesses. It offers an online multi-criteria searching tool connected to professional networks and peer recommendations, enabling companies to swiftly identify potential partners that align with their specific needs.
Univercells
Series C in 2020
Univercells is a company specializing in high-density, low-cost biomanufacturing solutions aimed at enhancing the production of biologics, including antibodies, proteins, and vaccines. The company leverages innovative engineering and proprietary technologies, such as single-use systems and continuous process intensification, to significantly reduce capital investments by over 75% and the cost of goods by up to 90%. Univercells offers a range of services, including scale-X hydro, scale-X carbo, and NevoLine, which support both research and development and commercial-scale production of biologics. Additionally, the company provides integrated services like equipment confirmation, capacity and facility design, and bioprocess excellence, facilitating the scalability of cell and gene therapy manufacturers from clinical trials to commercial manufacturing. Through its commitment to making biologics more accessible and affordable, Univercells addresses critical global health challenges.
Univercells
Series C in 2020
Univercells is a company specializing in high-density, low-cost biomanufacturing solutions aimed at enhancing the production of biologics, including antibodies, proteins, and vaccines. The company leverages innovative engineering and proprietary technologies, such as single-use systems and continuous process intensification, to significantly reduce capital investments by over 75% and the cost of goods by up to 90%. Univercells offers a range of services, including scale-X hydro, scale-X carbo, and NevoLine, which support both research and development and commercial-scale production of biologics. Additionally, the company provides integrated services like equipment confirmation, capacity and facility design, and bioprocess excellence, facilitating the scalability of cell and gene therapy manufacturers from clinical trials to commercial manufacturing. Through its commitment to making biologics more accessible and affordable, Univercells addresses critical global health challenges.
Yust Group
Seed Round in 2019
Yust is a company that offers lodging and hospitality services. The business offers housing, activities, meals, drinks, and services with an emphasis on art and culture, enabling urban residents and visitors to meet others who share their interests and travel at their own pace.
Graftys is an early-stage company based in Aix-en-Provence, France, focused on advanced bone biologics. It develops synthetic calcium phosphate bone graft substitutes that are fully injectable and designed for reconstructive orthopedic surgery. The company’s products target specific clinical applications, enabling standard options for bone reconstruction and trauma procedures. Through its biomaterials, Graftys aims to provide safe, predictable options for surgeons seeking injectable bone graft substitutes to support healing in challenging skeletal defects.
Univercells
Series B in 2018
Univercells is a company specializing in high-density, low-cost biomanufacturing solutions aimed at enhancing the production of biologics, including antibodies, proteins, and vaccines. The company leverages innovative engineering and proprietary technologies, such as single-use systems and continuous process intensification, to significantly reduce capital investments by over 75% and the cost of goods by up to 90%. Univercells offers a range of services, including scale-X hydro, scale-X carbo, and NevoLine, which support both research and development and commercial-scale production of biologics. Additionally, the company provides integrated services like equipment confirmation, capacity and facility design, and bioprocess excellence, facilitating the scalability of cell and gene therapy manufacturers from clinical trials to commercial manufacturing. Through its commitment to making biologics more accessible and affordable, Univercells addresses critical global health challenges.
3D-Side is a medical technology company that originated as a spin-off from UCL University, focusing on integrating 3D technology with surgical practices. The company specializes in developing three-dimensional cranial implants and advanced solutions for bone surgery, leveraging 3D software and additive manufacturing. 3D-Side has established a comprehensive ISO13485 workflow that enables the planning of complex surgical interventions. Their flagship product, Customize, is a web-based Software as a Service platform that includes tools for communication with surgeons, designing custom instruments or implants, and managing production. This system enhances the efficiency of surgical processes by allowing surgeons to easily send medical images, visualize 3D surgical plans, and supervise engineering tasks through a secure channel. By optimizing preoperative planning and reducing operating times, 3D-Side aims to improve patient outcomes and the overall efficiency of surgical practices.
BCI Pharma
Series A in 2017
BCI Pharma is a biotechnology firm specializing in the design and synthesis of kinase inhibitor libraries aimed at developing innovative treatments for various medical conditions, including inflammatory diseases, central nervous system disorders, and cancer. The company focuses on creating a kinase platform that facilitates the discovery of selective and potent kinase inhibitors through advanced screening technologies. BCI Pharma is dedicated to delivering effective medications while striving to earn the respect and recognition of patients, clients, investors, and the communities in which it operates. By combining medicinal chemistry with a commitment to innovation, BCI Pharma aims to contribute significantly to the advancement of targeted therapies in the healthcare sector.
BizMotica
Series A in 2017
Bezonia is a universal integration platform enabling people to orchestrate the most scalable technological ecosystems.
Lawbox is an online platform that offers personalized legal templates for businesses. Its service enables entrepreneurs to manage various legal formalities swiftly and cost-effectively through documents validated by experienced lawyers.
Vivalto Home
Series A in 2016
Vivalto Home is a provider of nursing homes and care residency services tailored for elderly individuals. The company operates a network of facilities that cater to the needs of autonomous, dependent, and disoriented seniors, offering them professional care and treatment. Vivalto Home's focus is on ensuring that elderly people have access to appropriate living arrangements and support, allowing them to receive the necessary assistance in a safe and caring environment.